PEDIATRIX MEDICAL GROUP INC (PDX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 234 transactions totaling $59.6M, demonstrating a bearish sentiment with -$59.3M in net insider flow. The most recent transaction on Feb 23, 2026 involved a sale of 20,300 shares valued at $411.3K.
No significant insider buying has been recorded for PDX in the recent period.
No significant insider selling has been recorded for PDX in the recent period.
Based on recent SEC filings, insider sentiment for PDX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$59.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PEDIATRIX MEDICAL GROUP INC (PDX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading PDX stock, having executed 234 transactions in the past 90 days. The most active insider is Joseph M. Calabro (Executive), who has made 57 transactions totaling $22.1M.
Get notified when executives and directors at PDX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Management, L.p. Saba Capital | Executive | Sale | 20,300 | $20.26 | $411.3K | |
| Feb 20, 2026 | Management, L.p. Saba Capital | Executive | Sale | 28,460 | $20.34 | $578.9K | Large |
| Feb 19, 2026 | Management, L.p. Saba Capital | Executive | Sale | 28,531 | $20.37 | $581.2K | Large |
| Feb 11, 2026 | Management, L.p. Saba Capital | Executive | Sale | 14,680 | $20.35 | $298.7K | |
| Feb 10, 2026 | Management, L.p. Saba Capital | Executive | Sale | 11,077 | $20.24 | $224.2K | |
| Feb 9, 2026 | Management, L.p. Saba Capital | Executive | Sale | 42,805 | $20.31 | $869.4K | Large |
| Feb 6, 2026 | Management, L.p. Saba Capital | Executive | Sale | 9,896 | $20.27 | $200.6K | |
| Feb 5, 2026 | Management, L.p. Saba Capital | Executive | Sale | 23,014 | $20.03 | $461.0K | |
| Jan 8, 2026 | Rappaport Alan | Executive | Purchase | 2,000 | $18.97 | $37.9K | |
| Dec 22, 2025 | Management, L.p. Saba Capital | Executive | Sale | 38,170 | $21.82 | $832.9K | Large |
| Nov 28, 2025 | Management, L.p. Saba Capital | Executive | Other | 654,907 | $N/A | $0 | |
| Sep 10, 2025 | Weinstein Boaz | Executive | Sale | 13,276 | $24.88 | $330.3K | |
| Sep 8, 2025 | Weinstein Boaz | Executive | Sale | 8,160 | $24.72 | $201.7K | |
| Sep 5, 2025 | Weinstein Boaz | Executive | Sale | 2,000 | $24.80 | $49.6K | |
| Sep 4, 2025 | Weinstein Boaz | Executive | Sale | 3,476 | $24.91 | $86.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 178 | $59.4M | 65.7% |
Exercise(M) | 26 | $20.8M | 23.0% |
Disposition(D) | 6 | $10.0M | 11.1% |
Purchase(P) | 3 | $167.5K | 0.2% |
Other(J) | 1 | $0 | 0.0% |
Award(A) | 18 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insider selling pressure at PEDIATRIX MEDICAL GROUP INC has increased, with 11 insiders executing 234 transactions across all time. Total sales of $59.4M significantly outpace purchases of $167.5K, resulting in a net outflow of $59.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.